ATE283057T1 - Austausch von t-lymphozyten - Google Patents

Austausch von t-lymphozyten

Info

Publication number
ATE283057T1
ATE283057T1 AT99401724T AT99401724T ATE283057T1 AT E283057 T1 ATE283057 T1 AT E283057T1 AT 99401724 T AT99401724 T AT 99401724T AT 99401724 T AT99401724 T AT 99401724T AT E283057 T1 ATE283057 T1 AT E283057T1
Authority
AT
Austria
Prior art keywords
lymphocytes
composition
exchange
population
subject
Prior art date
Application number
AT99401724T
Other languages
English (en)
Inventor
David Klatzmann
Jose Cohen
Olivier Boyer
Veronique Thomas-Vaslin
Jean-Loup Salzmann
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of ATE283057T1 publication Critical patent/ATE283057T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99401724T 1998-07-10 1999-07-08 Austausch von t-lymphozyten ATE283057T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9808952A FR2780891A1 (fr) 1998-07-10 1998-07-10 Echange de lymphocytes t

Publications (1)

Publication Number Publication Date
ATE283057T1 true ATE283057T1 (de) 2004-12-15

Family

ID=9528575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99401724T ATE283057T1 (de) 1998-07-10 1999-07-08 Austausch von t-lymphozyten

Country Status (7)

Country Link
EP (1) EP0972518B1 (de)
JP (1) JP2002520262A (de)
AT (1) ATE283057T1 (de)
DE (1) DE69922090T2 (de)
ES (1) ES2234220T3 (de)
FR (1) FR2780891A1 (de)
WO (1) WO2000002520A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US6867041B2 (en) 2000-02-24 2005-03-15 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
CA2781858C (en) 2000-05-12 2015-03-31 Genzyme Corporation Modulators of tnf-.alpha. signaling
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
EP1400534B1 (de) * 2002-09-10 2015-10-28 Affimed GmbH Menschlicher CD3-spezifischer Antikörper mit immunosupressiven Eigenschaften
TW200502391A (en) 2003-05-08 2005-01-16 Xcyte Therapies Inc Generation and isolation of antigen-specific t cells
EP2217698B1 (de) * 2007-10-12 2013-03-06 Université Pierre et Marie Curie (Paris 6) Verfahren für optimierte blutzellentransplantation
WO2009053629A2 (fr) * 2007-10-12 2009-04-30 Universite Pierre Et Marie Curie Traitement de tumeurs par des preparations de lymphocytes t

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06298654A (ja) * 1993-04-12 1994-10-25 Sumitomo Electric Ind Ltd 抗原特異的免疫抑制剤
US5595881A (en) * 1994-08-09 1997-01-21 Anergen, Inc. Method for the detection of antigen presenting cells
WO1996034956A1 (en) * 1995-05-04 1996-11-07 United States Of America, Represented By The Secretary Of The Navy Methods for modulating t cell survival by modulating bcl-xl protein level
JP2000511539A (ja) * 1996-05-31 2000-09-05 ジェネティック・セラピー・インコーポレイテッド 負の選択マーカーをコード化するポリヌクレオチドを含むｔ細胞による対宿主性移植片病の予防

Also Published As

Publication number Publication date
WO2000002520A2 (fr) 2000-01-20
ES2234220T3 (es) 2005-06-16
EP0972518A3 (de) 2000-01-26
EP0972518A2 (de) 2000-01-19
EP0972518B1 (de) 2004-11-24
JP2002520262A (ja) 2002-07-09
DE69922090D1 (de) 2004-12-30
FR2780891A1 (fr) 2000-01-14
WO2000002520A3 (fr) 2000-03-23
DE69922090T2 (de) 2005-12-01

Similar Documents

Publication Publication Date Title
FR2606028B1 (fr) Systeme a enzyme stabilisee, procede pour le preparer, compositions detergentes le contenant et leurs procedes d'utilisation pour nettoyer des tissus salis
NZ222373A (en) Antihypertensive agents and pharmaceutical compositions containing nor-statine and cyclostatine
NZ222977A (en) Aminotetralins and pharmaceutical compositions; 8-substituted-2-aminotetralins and pharmaceutical compositions thereof
FR2628317B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
EP0737700A3 (de) Blockcopolymer enthaltendes Trennmittel, Diaminvorläufer und Verfahren zu ihrer Herstellung und daraus hergestellte Produkte die das Trennmittel enthalten
DE69102707D1 (de) In einem DNA - Gel stabilisierte Heilwasserliposomen.
ATE283057T1 (de) Austausch von t-lymphozyten
EP0243616A3 (en) Liquid preparations of 1,2-benzisothiazol-in-3-one
IT1222763B (it) Dispositivo per la separazione di impurita',come rifiuti,pelature e simili per una carda
IT8883551A0 (it) Procedimento per l'estrazione e la purificazione di dna
FR2604180B1 (fr) Composition d'organopolysiloxane
HUT43829A (en) Process for producing 1,1-disubstituted cyclopropan derivatives and pharmaceutical and/or fungicide compositions containing them as active agents
FR2606677B1 (fr) Applicateur de liquide, par exemple applicateur de produit de beaute, instrument d'ecriture, etc.
FR2580494B1 (fr) Composition cosmetique pour le traitement des cheveux, notamment des cheveux gras a base d'un extrait de millefeuille (achillea millefolium l)
PT82554A (en) Process for the preparation of (2,4,5-cis)dioxane and compositions therewith
MTP1014B (en) Substituted aminopropionamides,a process for their preparation,agents containing them,and their use,and new intermediates produced in the preparation (hoe 861f 302)
FR2605435B3 (fr) Panneau d'affichage
NZ219719A (en) Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
IL80733A0 (en) 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
FR2763596B1 (fr) Produits stabilisants, compositions et concentres les contenant, et leur procede d'utilisation
IT8720208A0 (it) Macchina per l'impiego forestale destinata in particolare per la lavorazione di alberi.
BR8603969A (pt) Projeto de consumo e vendas diretas do produtor
Yoshihashi Interaction Design

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties